Literature DB >> 1759839

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

J A García-Rodriguez1, J E García Sánchez, J L Muñoz Bellido, T Nebreda Mayoral, E García Sánchez, I García García.   

Abstract

Corynebacterium group D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a number of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. beta-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1759839      PMCID： PMC245342          DOI： 10.1128/AAC.35.10.2140

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin.

Authors:  F Soriano; R Fernández-Roblas; J Zapardiel; J L Rodríguez-Tudela; P Avilés; M Romero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.

Authors:  R Fernández-Roblas; S Prieto; M Santamaría; C Ponte; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  Serious infections caused by diphtheroids.

Authors:  W D Johnson; D Kaye
Journal:  Ann N Y Acad Sci       Date:  1970-10-30       Impact factor: 5.691

5.  Antimicrobial susceptibility of Corynebacterium group D2.

Authors:  M Santamaría; C Ponte; I Wilhelmi; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Bacteriuria with a multiply resistant species of Corynebacterium (Corynebacterium group D2): an unnoticed cause of urinary tract infection.

Authors:  J M Aguado; C Ponte; F Soriano
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

7.  Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.

Authors:  F Soriano; C Ponte; M Santamaría; A Torres; R Fernández-Roblas
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

8.  [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].

Authors:  N Marty; D Clave; B Cancet; S Henry-Ferry; J Didier
Journal:  Pathol Biol (Paris)       Date:  1988-05

9.  Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).

Authors:  G Verschraegen; G Claeys; A M Van den Abeele
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

10.  In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum).

Authors:  F Soriano; C Ponte; M Santamaría; C Castilla; R Fernández Roblas
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948
  10 in total
  19 in total

1.  Antimicrobial susceptibility pattern of Corynebacterium striatum.

Authors:  L Martínez-Martínez; A Pascual; K Bernard; A I Suárez
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 2.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

3.  Incidence and characteristics of urinary tract infections caused by Corynebacterium urealyticum (Corynebacterium group D2).

Authors:  T Nebreda-Mayoral; J L Muñoz-Bellido; J A Garcia-Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

4.  Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria.

Authors:  L Martínez-Martínez; M C Ortega; A I Suárez
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.

Authors:  K Weiss; M Laverdière; R Rivest
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Comparative in vitro activities of new quinolones against coryneform bacteria.

Authors:  L Martínez-Martínez; A I Suárez; M C Ortega; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

8.  In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Authors:  L Martínez-Martínez; A Pascual; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Influence of external factors in resistance of Corynebacterium urealyticum to antimicrobial agents.

Authors:  M Garcia-Bravo; J M Aguado; J M Morales; A R Noriega
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

10.  Prevalence of Corynebacterium urealyticum in urine specimens collected at a university-affiliated medical center.

Authors:  M Ryan; P R Murray
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.